StockData
Ovid Therapeutics Inc. logo

Ovid Therapeutics Inc. (OVID) stock

OVIDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 10/30
$2.22−0.18 (-7.50%)

Close on Nov 17, 2026Market cap $433.56MP/E –Yield –

Ovid Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

No gross margin figures for Ovid Therapeutics

Ovid Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Ovid Therapeutics figures

See a number that looks wrong?